EGFR and non-small cell lung carcinoma: In NSCLC, and especially in lung adenocarcinomas, signaling of kirsten human rat sarcoma protein (KRAS), a main downstream signaling molecule of EGFR pathway, is frequently influenced by its own somatic mutations [96, 97].